Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - docetaxel 10 mg/ml - concentrate for infusion - 80 mg/8ml - active: docetaxel 10 mg/ml excipient: citric acid ethanol nitrogen polysorbate 80 - metastatic breast cancer docetaxel sandoz is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. docetaxel sandoz in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - doxazosin mesilate - oral tablet - 4mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - doxazosin mesilate - oral tablet - 4mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

sterwin medicines - doxazosin mesilate - oral tablet - 4mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - doxazosin mesilate - oral tablet - 4mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - doxazosin mesilate - oral tablet - 4mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - doxazosin mesilate - oral tablet - 4mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - doxazosin mesilate - oral tablet - 4mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - doxazosin mesilate - oral tablet - 4mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - pergolide mesilate - oral tablet - 1mg